[{"Assets_0_Q3_USD":72675000.0,"CommonStockSharesOutstanding_0_Q3_shares":41457155.0,"NetIncomeLoss_1_Q3_USD":-10684000.0,"NetIncomeLoss_3_Q3_USD":-30455000.0,"StockholdersEquity_0_Q3_USD":45749000.0,"Ticker":"FATE","CIK":"1434316","name":"FATE THERAPEUTICS INC","OfficialName":"Fate Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3545646272.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171101"}]